Cancer Immunotherapy / Immuno-Oncology & Acute myeloid leukemia (AML)

• Cancer Immunotherapy / Immuno-Oncology in Acute myeloid leukemia (AML) is active and promising (1, 2)


• It is not yet a broadly established standalone treatment class (1, 2)


• The field focuses on (1, 2):
  
  
  • Targeted antibodies
  
  
  • Cellular therapies
  
  
  • Checkpoint modulation
  
  
  • Vaccines
  
  
  • Transplant-related immune effects
  
  
  
  


• These approaches are mostly in clinical trials or selected settings (1, 2).


• They are not commonly used as routine frontline monotherapy (1, 2).

References

(1) Wang et al. 2025 Front. Immunol. 16: 1505247
(2) Maurer et al. 2022 Int J Mol Sci 23(24): 15907

see also:
[Acute myeloid leukemia (AML) & Drugs/Treatments](brain://b1Do_aCZNEmvLEHvkSukYQ/AcuteMyeloi…